(Q34424267)

2 August 2017

1 reference

title

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. (English)

1 reference

2 August 2017

1 reference

2

J R Geddes

1 reference

2 August 2017

5

G M Goodwin

1 reference

2 August 2017

K A Macritchie

1

1 reference

2 August 2017

J Scott

series ordinal

3

1 reference

2 August 2017

D R Haslam

series ordinal

4

1 reference

2 August 2017

language of work or name

1 reference

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

2 August 2017

published in

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

CD003196

1 reference

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Role of newer medications for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Predictors of response to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Clinical Factors in Lithium Carbonate Prophylaxis Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

The hazards of scoring the quality of clinical trials for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Lithium: evidence reconsidered

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Bipolar mood disorder: practical strategies for acute and maintenance phase treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Is there a lithium withdrawal syndrome? An examination of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

The psychiatric status schedule. A technique for evaluating psychopathology and impairment in role functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003196

10.1002/14651858.CD003196

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference